Neuroendocrine Theory

What it proposes

Vladimir Dilman (1925–1994) argued that aging is fundamentally a regulatory disease of the hypothalamus. Set-points for glucose, sex hormones, growth hormone, and other axes drift with age, generating the pattern of age-related dysregulation across multiple systems.

Key claims:

• Hypothalamic sensitivity to feedback inhibition declines, raising set-points for cortisol, GH, sex hormones.
• This drives metabolic syndrome, immunosenescence, and reproductive decline.
• Restoring hypothalamic regulation might reverse aspects of aging.

Modern resonance

• Hypothalamic inflammation (NF-κB activation) drives systemic aging in mice (Cai lab work).
• Hypothalamic stem cells decline with age and their restoration extends mouse lifespan modestly.
• The leptin–melanocortin set-point shift explains some adiposity drift with age.
• GLP-1 and GIP agonists effectively reset hypothalamic appetite regulation, supporting the framing.

What it doesn’t cover

• Cell-autonomous aging mechanisms (telomere, DNA-damage, mitochondrial).
• Why aging proceeds in tissues lacking direct hypothalamic regulation.

Status

The neuroendocrine theory has been re-invigorated in modern geroscience as a complement to (not replacement for) damage-accumulation theories. The hypothalamus is increasingly recognised as one of the central pacemaker tissues of mammalian aging.

Related entries

Altered intercellular communication, Cortisol (4-point), Klotho, Disposable soma theory.